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Tostudyeffectsofmitochondrial complex I (CI,NADH:
ubiquinone oxidoreductase) deficiency, we inacti-
vated the Ndufs4 gene, which encodes an 18 kDa
subunit of the 45-protein CI complex. Although small,
Ndufs4knockout (KO)miceappearedhealthy until5
weeks of age, when ataxic signs began, progressing
to death at7 weeks. KO mice manifested encepha-
lomyopathy including a retarded growth rate, leth-
argy, loss of motor skill, blindness, and elevated se-
rum lactate. CI activity in submitochondrial particles
from KO mice was undetectable by spectrophoto-
metric assays. However, CI-driven oxygen consump-
tion by intact tissue was about half that of controls.
Native gel electrophoresis revealed reduced levels
of intact CI. Thesedata suggest that CI fails to assem-
ble properly or is unstable without NDUFS4. KO
muscle has normal morphology but low NADH dehy-
drogenase activity and subsarcolemmal aggregates
of mitochondria. Nonetheless, total oxygen con-
sumption and muscle ATP and phosphocreatine
concentrations measured in vivo were within normal
parameters.
INTRODUCTION
Mitochondria play vital roles in energy production, Ca2+ buffer-
ing, apoptotic events, and production of reactive oxygen species
(ROS) (Nemoto et al., 2000; Sayer, 2002; Schapira, 1996; Smith
et al., 2000; Wallace, 1999). Given these essential functions, it is
not surprising that mitochondrial failure is implicated in a wide
variety of diseases, generally involving tissues with high-energy
demand (Coskun et al., 2004; Finsterer, 2006; Kim et al., 2001;
Orth and Schapira, 2002; Zeviani et al., 1998). Neural, muscular,
and cardiac pathologies frequently result from dysfunctional mi-
tochondria, and progressive encephalomyopathy is a common
clinical phenotype. Mitochondrial complex I (CI)-associated de-
fects are the most common mitochondrial disorders (Benit et al.,
2003; Kirby et al., 1999; Loeffen et al., 2000; Petruzzella and
Papa, 2002; Smeitink et al., 2001). CI is the primary entry point312 Cell Metabolism 7, 312–320, April 2008 ª2008 Elsevier Inc.for electrons into the electron transport chain (ETC) and is com-
prised of at least 45 different proteins (Carroll et al., 2006). De-
fects in the nonenzymatic, nuclear-encoded CI protein NADH:
ubiquinone oxidoreductase iron-sulfur protein 4 (NDUFS4,
18 kDa) cause a Leigh-like phenotype in humans that results in
death within 3–16 months after birth (Budde et al., 2000, 2003;
Petruzzella et al., 2001; van den Heuvel et al., 1998). Findings
in patients with NDUFS4 mutations include retarded growth,
developmental delay, visual defects, muscular hypotonia, en-
cephalomyopathy, cardiomyopathy, lethargy, and failure to thrive
(Budde et al., 2003; Petruzzella et al., 2001; Scacco et al.,
2003; Ugalde et al., 2004; van den Heuvel et al., 1998). In humans,
NDUFS4 appears to be essential for proper assembly of CI
(Petruzzella et al., 2001; Scacco et al., 2003; Vogel et al., 2007).
Despite the importanceof mitochondria and the manydisorders
that result from cellular respiratory dysfunction, there are few
genetic models of mitochondria-associated disease. Although
other mouse models indirectly affect CI activity (Larsson et al.,
1998; Park et al., 2007; Vahsen et al., 2004), none involve a CI-
specific mutation. We created a mutation of a CI subunit gene
(Ndufs4). In this paper, we describe the mitochondrial enceph-
alomyopathy phenotype of these Ndufs4 knockout (KO) mice.
RESULTS
Phenotype of Ndufs4 Null Mice
Mice with a conditional allele of the Ndufs4 gene (exon 2 flanked
by loxP sites) were generated (see Figures S1A and S1B avail-
able online). Homozygous Ndufs4lox/lox mice appear normal;
however, deletion of exon 2 in all cells (Ndufs4D/D = KO) caused
the severe phenotype described below. Exon 2 encodes the last
part of a mitochondrial targeting sequence and the first 17 amino
acids of the mature NDUFS4 protein. Excision of exon 2 pro-
duces a frameshift that precludes synthesis of mature NDUFS4
protein. NDUFS4 was undetectable in protein extracts from KO
mice by western blot (Figure S1C).
Mice heterozygous (HET) for the deleted Ndufs4 allele were in-
distinguishable from wild-type (WT) mice. By postnatal day 21
(P21), most KO mice were smaller than normal and had begun
to lose their body hair; however, their hair grew back during
the next hair-growth cycle (Figure S2). KO mice reached a maxi-
mum body weight of15 g atP30 (Figure 1A). Prior to P30, the
KO mice groomed, fed, responded to novel objects, socialized,
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(A) Growth curves of wild-type (WT), heterozygous (HET), and Ndufs4 knockout (KO) female mice. KO mice weigh significantly less than either WT or HET mice.
n = 4–56, depending on day and genotype. p < 0.05 for all time points beyond postnatal day 15 (P15) by Student’s two-tailed t test.
(B) Locomotor activity of young (<P30) KO mice is comparable to WT and HET (CT), but older (>P30) KO mice become hypoactive. *p = 0.0001 between old CT
mice and old KO mice by Student’s two-tailed t test.
(C) Oxygen consumption (l/kg lean mass/hr) by P26–P37 KO mice over 72 hr in metabolic chambers was the same as controls during daytime, nighttime, and
fasting. n = 9 WT; n = 7 KO. pR 0.5 for diurnal, nocturnal, and fasting measurements.
(D) Body temperature of >P30 KO mice was 2C lower than controls. n = 3–9, depending on day and genotype. p < 0.001 for all days beyond P30 by Student’s
two-tailed t test.
(E) Electroretinograms from P21 KO mice lack the B wave, indicating failure of neurotransmission from photoreceptors to bipolar cells. Traces from four WT and
two KO mice are superimposed.
(F) Startle responses (in arbitrary units) of KO mice were enhanced relative to WT mice until P36. n = 14 <P36 WT; n = 14 <P36 KO. *p < 0.0001 for 90, 100, 105, and
110 dB by Student’s two-tailed t test. Inset: repeated measurements of older KO mice (two examples shown) revealed progressive loss of startle response, but
with variable age of onset. SR (% max) is the percent of maximum startle response.
(G) Rotarod performance (latency to fall) of young (<P20) KO mice is normal; however, at older ages, their performance is significantly worse than WT mice. By
P40, KO mice could not remain on an immobile rotarod for long enough to begin the experiment. n > 20 CT; n = 4 KO. *p < 0.0003 for all ages beyond P21 by
Student’s two-tailed t test.
Values given as mean ± SD in (A) and as mean ± SEM in (B)–(D), (F), and (G).Cell Metabolism 7, 312–320, April 2008 ª2008 Elsevier Inc. 313
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(A) Submitochondrial particles (SMPs) derived from KO liver had no mitochon-
drial complex I (CI) activity, whereas complex III (CIII) and complex IV (CIV) ac-
tivities were not significantly different. CII activity was significantly higher. Data
were normalized to citrate synthase activity (D absorbance/min of respiratory
complex activity: (D absorbance/min citrate synthase activity), hence they
have no units. Assays were performed in triplicate. n = 12 for CI, CII, and
CIV; n = 4 for CIII. *p = 0.003; **p = 0.0001 by Mann-Whitney test. Similar re-
sults were obtained with SMPs from brain and murine embryonic fibroblasts
(MEFs).
(B) Rates of O2 consumption by liver CI from P35 WT and KO mice. Arrows in-
dicate addition of (1) tissue, (2) ADP, (3) malate/pyruvate, and (4) rotenone.
There was less O2 consumption by KO tissue relative to WT in the presence
of malate/pyruvate (a CI-specific substrate), and O2 consumption stopped
with addition of rotenone.
(C) The ratio of O2 consumption (l/mg tissue/min) in liver cells from KO mice
versus WT mice. CI activity of KO tissue is less than half that of WT, whereas
CII and CIV activities do not significantly differ. n = 5. *p = 0.0001 by Student’s
two-tailed t test. Similar results were obtained in brain and muscle.314 Cell Metabolism 7, 312–320, April 2008 ª2008 Elsevier Inc.and generally behaved similarly to control mice. They had normal
locomotor activity during both day and night until P30, after
which they became lethargic (Figure 1B). Total oxygen con-
sumption (Figure 1C), CO2 clearance, and food consumption
by KO mice during both day and night and during a fast were
within normal ranges when measured over 2 days in metabolic
chambers (data not shown), but body temperature was 2C
lower than controls after P30 (Figure 1D). KO mice were blind,
which manifested as an absent B wave in an electroretinogram
(Figure 1E) and failure to recognize a visual cliff (data not shown).
As early as P20, cataracts sometimes appeared in one or both
eyes; after P35, KO mice were often unable to open their eyes
completely. The acoustic startle response of KO mice was
similar to (and often exceeded) that of controls until P35
(Figure 1F). After P35, but with variable time of onset, there
was a rapid decline in startle response (Figure 1F, inset), such
that some older KO mice (n = 4) no longer responded tones up
to 120 dB. Starting at P35, the KO mice developed severe
ataxia: they had splayed legs, became unresponsive to a firm
nudge, were slow and awkward at righting themselves, and
sometimes would lose their balance and fall over. These older
KO mice were unable to maintain balance on a 0.7 mm-wide
ledge, failed a negative geotaxis test, attempted to clasp
a hind leg when suspended by their tail, and could not remain
on a rotarod as long as controls (Figure 1G). Light microscopic
studies of sections from cerebrum, brainstem, cerebellum, and
eye did not reveal any significant differences between KO and
WT mice at P35. In particular, infarcts, neuronal loss, and gliosis
were not evident in sections stained with either cresyl violet or
hematoxylin and eosin (data not shown). Between P35 and
P50, the KO mice stopped gaining weight, displayed worsened
ataxia, ceased grooming, and died.
Measurement of CI Activity and Abundance
Enriched mitochondrial samples were prepared from liver to
measure respiratory capacity. Rotenone-sensitive CI activity
was detected in submitochondrial particles (SMPs) isolated
from WT and HET samples, but not from KO samples (Figure 2A).
The maximal enzymatic activity of respiratory complex II (CII) of
KO mice was significantly higher. Activities of complex III (CIII)
and complex IV (CIV) of KO mice were comparable to control
samples (Figure 2A), although CIII activity of KO mice tended
to be lower.
In contrast to the results obtained with SMPs, CI activity was
detectable in intact KO cells (Figures 2B and 2C; Figure S3).
The activities of CI, CII, and CIV were measured by monitoring
oxygen consumption using a Clarke electrode. Complex activity
measured in this manner implies coupling of a functional respira-
tory chain with oxygen as the final electron acceptor. Amounts of
oxygen consumption by tissue samples from KO and control
(D) Blue native gel electrophoresis (BNGE) of CI from brain and liver mitochon-
dria. Proteins representing the three major CI subcomplexes were examined
by western blot; in each case, KO mitochondria had less intact CI.
(E) SDS-PAGE of proteins representing the three major subcomplexes of CI.
Equivalent amounts of mitochondrial protein were loaded, and manganese
superoxide dismutase (MnSOD) was used as an internal standard. The
samples were the same as those used for the BNGE experiment in (D).
Values in (A) and (C) are given as mean ± SEM.
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Encephalomyopathy in Complex I-Deficient MiceFigure 3. ATP Turnover Reactions during
Ischemia Reperfusion in Hindlimb Muscles
In Vivo
(A) Representative data illustrating phosphocrea-
tine (PCr), and inorganic phosphate (Pi) dynamics
during ischemia and reperfusion. Resting ATPase
(equivalent to ATP demand) is equal to the initial
rate of PCr breakdown during ischemia (black
regression line). The phosphorylation capacity is
calculated from the recovery of PCr following
ischemia (Blei et al., 1993).
(B) Resting mitochondrial ATPase (equivalent to
resting ATP demand) is not different in WT (dark
gray bars) and KO (gray bars) mice. n = 6 (WT);
n = 5 (KO). p = 0.13.
(C) Phosphorylation capacity is not significantly
different in skeletal muscle of WT and KO mice.
n = 6 for both WT and KO; p = 0.12.
Values in (B) and (C) are given as mean ± SEM.mice were always measured in parallel. CI activity of tissues from
KO mice was about half that of controls, whereas CII and CIV ac-
tivities were equivalent or slightly higher than controls (Figure 2C).
Detection of rotenone-sensitive oxygen consumption in intact
tissue but lack of CI activity in SMPs suggests that functional
CI is unstable during preparation of SMPs in the absence of
NDUFS4.
The abundance of CI in mitochondria from liver and brain was
assessed by blue native gel electrophoresis (BNGE). Equal
amounts of mitochondria were loaded, electrophoresed, blotted,
and then probed with antibodies to three different CI subunits
(NDUFS3, NDUFB6, and NDUFA9) located in different parts of
the complex (Figure S4A). The abundance of intact CI was re-
duced in mitochondria from liver and brain of KO mice compared
to controls (Figure 2D). However, SDS-PAGE analysis of the
same samples with the three antibodies gave equivalent signals
from WT and KO tissue (Figure 2E). These results indicate that
although individual subunits of CI are present at comparable
amounts, the amount of intact CI is reduced in mitochondria
from KO mice, which could account for the lower oxygen con-
sumption by KO tissue.
Muscle Physiology and Metabolite Measurements
We used 31P-NMR spectroscopy to measure ATP turnover reac-
tions and ATP, phosphocreatine (PCr), and inorganic phosphate
(Pi) concentrations during hindlimb ischemia reperfusion in vivo.
Resting O2 consumption rate was measured using optical spec-
troscopy of hemoglobin and myoglobin saturations in vivo. Dur-
ing ischemia, PCr was depleted while Pi increased (Figure 3A);
when oxygen flow was restored, PCr returned to normal levels.
The rate of PCr recovery following ischemia was used to deter-
mine the mitochondrial phosphorylation capacity (maximal mito-
chondrial ATP production). Resting ATP demand (Figure 3B),
phosphorylation capacity (Figure 3C), and resting O2 consump-
tion (data not shown) were not different between control and KOmice. At the end of the experiment, total muscle ATP and PCr
were measured. Muscle from P30 KO mice had ATP levels at
the low end of the normal range, but PCr, Cr, and Pi were normal
(Table 1).
Fasting blood glucose concentration was not significantly dif-
ferent between KO mice and controls. Old (>P40) KO mice had
slightly elevated serum lactate levels (1.63 ± 0.18 mM; Table 1),
whereas young (P18) KO mice had lactate levels similar to WT
mice (data not shown).
Muscle Mitochondria and Histochemistry
The relative mitochondrial genome number was quantified by
Southern blot analysis of total DNA isolated from brain, heart,
kidney, liver, and soleus muscle of >P35 control and KO mice
using a mouse mitochondrial DNA probe. The intensity of the mi-
tochondrial DNA band relative to a nuclear gene from KO tissues
was the same as controls (Figure S5). Electron microscopy was
used to examine mitochondrial morphology and density in
muscle tissue. Mitochondrial ultrastructure appeared normal,
although large subsarcolemmal clusters of mitochondria were
present in the soleus but not extensor digitorum longus (EDL)
muscle fibers of KO mice (Figure 4A).
Both glycolytic and oxidative muscles of >P30 KO mice had
normal polygonal morphology with peripheral nuclei (Figure 4B).
Muscle of control and KO mice appeared normal after staining
using the Gomori trichrome method, and there was no evidence
of a ‘‘ragged-red’’ fiber phenotype. All muscle fiber types were
present as shown by myofibrillar ATPase staining in various mus-
cles including tibialis anterioris and soleus muscle. Succinate
dehydrogenase (SDH) stain intensity often appeared slightly
darker for KO mice, although quantitative analysis revealed no
difference. There was a marked decrease in NADH oxidase
activity in KO muscle fibers, while cytochrome c oxidase (COX)
activity was comparable in both control and KO muscle
(Figure 4B).Cell Metabolism 7, 312–320, April 2008 ª2008 Elsevier Inc. 315
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Genotype ATP Pi PCr Cr Glucose Lactate
WT or CT 9.13 ± 0.50 4.04 ± 0.68 26.89 ± 1.98 13.31 ± 2.01 7.98 ± 0.49 1.26 ± 0.06
KO 7.85 ± 0.59 3.09 ± 0.40 25.77 ± 2.28 15.08 ± 1.42 7.48 ± 1.32y 1.63 ± 0.18*
ATP, inorganic phosphate (Pi), phosphocreatine (PCr), and creatine (Cr) levels from muscle (given in mmol/g wet tissue weight) were measured in P30
mice (n = 6 WT; n = 5 KO) by high-pressure liquid chromatography using a photodiode array detector. Blood glucose (given in mM) was measured in
P22–72 mice (n = 22 CT [WT and HET]; n = 13 KO). Blood lactate (given in mM) was measured in P18–56 CT mice (n = 24) and >P40 KO mice (n = 8).
Values are mean ± SEM. *p = 0.03; yp = 0.12 versus CT by Student’s two-tailed t test.DISCUSSION
We have described the phenotype of a mouse model of CI defi-
ciency caused by mutating one of its 45 subunits. Respiratory CI
activity was impaired in the absence of NDUFS4 protein and a fa-
tal phenotype developed, similar to the Leigh-like encephalo-
myopathy observed in humans with mutations in NDUFS4. In
the absence of NDUFS4, the abundance of CI and the rate of
CI-driven oxygen consumption by intact cells were significantly
reduced. Nevertheless, ATP, PCr, glucose, and lactate levels
were close to normal, and total oxygen consumption in KO
mice was unaffected. Although their growth was retarded, the ac-
tivity and behavior of KO mice were similar to WT mice during the
first 4 weeks; this was followed by increasing lethargy, although
oxygen consumption remained constant. After P35, KO mice
suffered from rapid deterioration of motor ability, lost weight,
and usually died by P50.
We confirmed CI dysfunction in Ndufs4 KO mice. It was sur-
prising that SMPs isolated from mitochondria of KO mice had
no detectable CI activity when reduction of a ubiquinone deriva-
tive was measured, yet the KO mice lived 5 weeks before dis-
playing severe signs of illness, and their total oxygen consump-
tion appeared normal. We suspected that CI was at least partially
functional in KO tissue and confirmed this by monitoring oxygen
uptake in intact mitochondria. CI-dependent (rotenone-sensi-
tive) oxygen consumption was evident in tissue from KO mice,
although at less than half the rate of control tissue. The residual
CI activity in intact mitochondria from KO mice had the same ro-
tenone sensitivity as controls (data not shown). The presence of
some intact CI explains why ATP levels of skeletal muscle in vivo
were normal and ATP was regenerated after ischemia at a rate
equivalent to WT. The activities of the other respiratory com-
plexes were normal or slightly elevated, in agreement with stud-
ies using human fibroblasts and skeletal muscle with NDUFS4
mutations (Budde et al., 2000; van den Heuvel et al., 1998).
Mutations in human NDUFS4 also abolish CI activity in SMPs,
and this loss of activity is associated with the appearance of
large subcomplexes, suggesting that the stability or assembly
of intact CI is affected (Petruzzella et al., 2001; Scacco et al.,
2003; Vogel et al., 2007). When CI from KO mice was examined
by BNGE, the results indicated that the abundance of intact CI
was reduced, in agreement with reduced CI activity. There was
no evidence of subcomplexes as reported for NDUFS4 muta-
tions in human fibroblasts. The difference between our results
and those reported for human NDUFS4 mutations could reflect
differential effects of the native gel electrophoresis methods
used to analyze CI integrity or different stability of the remaining
CI components in the absence of NDUFS4 in the two species.
Both species exhibit an absence of CI activity in SMPs.316 Cell Metabolism 7, 312–320, April 2008 ª2008 Elsevier Inc.The failure of the spectrophotometric methods to record mea-
surable CI activity may be due to the preparation of SMPs. Son-
ication, freeze-thaw, or detergents are used to fracture mito-
chondria and thereby allow access of substrates to the inner
mitochondrial membrane. We hypothesize that these manipula-
tions disrupt an already compromised complex, resulting in
complete loss of activity. The nonfunctional subcomplex of hu-
man NDUFS4-deficient fibroblasts may represent an intermedi-
ate of an unstable complex under these conditions. Because hu-
mans with complete loss of NDUFS4 survive for several months,
we suspect that they too retain some CI activity and that fibro-
blast cell lines derived from patients may not represent the situ-
ation in vivo. Alternatively, mice and humans may respond differ-
ently to NDUFS4 deficiency. Our observation that some intact CI
can form in the absence of NDUFS4 suggests that this subunit
plays an important role in the assembly or stability of the com-
plex but that the intact complex can form without it, perhaps
because of compensation by other proteins.
We examined whether metabolite levels were affected by CI
deficiency. Serum lactate was slightly higher in the older mice,
but not enough to suggest toxic acidosis. Lowered CI activity
may result in accumulation of NADH, which would negatively af-
fect energy flux, and reduce lactate dehydrogenase activity.
Lactic acidosis occurs in humans with dysfunctional mitochon-
dria, including patients with Leigh syndrome, although not usu-
ally in patients with NDUFS4 mutations, in agreement with our
data (Loeffen et al., 2000). Blood glucose levels were also
normal. NADH oxidase was reduced in muscle from KO mice,
substantiating a CI deficiency. Despite the decrease of NADH
oxidase activity, muscle morphology appeared normal, sup-
porting the idea that some functional CI is retained in muscle
from KO mice. COX staining of KO muscle was comparable
but sometimes appeared slightly less intense than controls in
highly oxidative muscle such as the soleus. Lower COX activity
has been observed when SDH activity is increased (Lopez
et al., 2000; Rifai et al., 1995). SDH staining in oxidative muscle
of KO mice is sometimes more intense than controls, and CII-
driven O2 consumption is often slightly higher than controls. Fur-
thermore, mitochondria isolated from KO mice are capable of
supporting significantly higher CII activity, suggesting that CII
substrate delivered in vivo could have therapeutic properties.
Although dysfunctional mitochondria sometimes accumulate to
extraordinary quantities in muscle from individuals with mito-
chondrial dysfunction (Schmiedel et al., 2003), Southern blot
analysis indicated that the mitochondrial genome numbers
from muscle and three other organs of KO mice were normal.
Electron microscopy revealed subsarcolemmal accumulation
of mitochondria in a subset of highly oxidative KO muscle
fibers. In spite of this, ragged-red muscle fibers, which reflect
Cell Metabolism
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Muscle from KO and WT Mice
(A) Electron microscopy images of the subsarco-
lemmal layer of P35 soleus muscle. Larger subsar-
colemmal clusters of mitochondria (six or more mi-
tochondria deep) were observed in 50% of soleus
muscle fibers from KO mice, versus no fibers with
clusters greater than five mitochondria deep in WT
soleus.
(B) Light microscopy of highly oxidative soleus
muscle from a P23 WT and a P23 KO mouse. Gly-
colytic (type IIB, white arrows) and slow oxidative
(type I, black arrows) fibers are indicated. Hema-
toxylin and eosin (H&E) were used to stain muscle
fibers. Gomori trichrome staining shows no ‘‘rag-
ged-red’’ fibers. Myofibrillar ATPase staining
reveals fiber types. Quantitative analysis of slides
of four mice of each genotype revealed no signifi-
cant difference in fraction of glycolytic fibers. Suc-
cinate dehydrogenase (SDH) stain intensity often
appears slightly darker for KO mice, especially in
oxidative muscle fibers identified by ATPase stain-
ing. Quantitative analysis of slides of five mice of
each genotype revealed no significant difference.
NADH oxidase activity of soleus muscle is lower
in KO muscle, primarily in the slow oxidative fibers.
Cytochrome oxidase (COX) staining of KO mice is
comparable to WT.accumulation of dysfunctional mitochondria in the subsarco-
lemmal region, were not detectable by the Gomori trichrome
method. Muscle fiber morphology of KO mice was normal, sim-
ilar to the histology of muscle taken from human Leigh syndrome
patients (Loeffen et al., 2000; Munaro et al., 1997; van den
Heuvel et al., 1998). This is compatible with our observation
that total mitochondria content is normal.
Ndufs4 KO mice die at an early age despite having ATP and
glucose levels that are within normal parameters. The absence
of deficits in resting ATP levels and rates of ATP production sug-
gests that compromised basal energetics in peripheral tissue is
not the cause of death. However, the inability to produce higher
amounts of ATP in tissues that have an increasing need for effi-
cient oxidative phosphorylation, such as the maturing brain, may
cause cumulative detrimental effects. Mice deficient in NDUFS4
only in neurons and glia (Nestin-Cre KO) have a phenotype
essentially the same as the complete KO mice described here
(unpublished data). Indirect effects of CI deficiency could also
cause encephalomyopathy. Abnormal mitochondrial trafficking,
altered cell signaling, ROS production, and/or impaired Ca2+
buffering may be responsible for the severe phenotype of KO
mice. Manganese superoxide dismutase (MnSOD) expression
increases when CI deficiency produces oxidative stress (Abid
et al., 2004; Robinson, 1998); however, MnSOD levels in mito-
chondria from KO mice were normal. Likewise, enhanced levels
of superoxides are not detected in human fibroblasts from
NDUFS4-deficient patients (Iuso et al., 2006; Piccoli et al.,2006). Furthermore, KO fibroblast and neuron cultures did not
exhibit increased ROS or cell death (data not shown), arguing
against the role of ROS in CI disease.
The mechanisms of ataxic onset and failure to thrive have not
yet been determined, although dysfunctional mitochondria have
been associated with a variety of central nervous system disor-
ders and neurodegenerative diseases (Coskun et al., 2004; Fin-
sterer, 2006; Kim et al., 2001; Orth and Schapira, 2002; Wallace,
1999; Zeviani et al., 1998). Given that the older KO mice suffer
from defective vision, ataxia, loss of acoustic startle response,
and hypoactivity, it is likely that a neuronal deficiency is respon-
sible for their encephalomyopathy. The exaggerated startle
response of KO mice may reflect a loss of inhibitory neuron func-
tion (Rajendra et al., 1994). Furthermore, loss of apoptosis-
inducing factor (AIF) results in reduced CI content and affects
primarily the brain and retina (Vahsen et al., 2004), emphasizing
the sensitivity of neurons to metabolic deficiencies. Interestingly,
KO mice have a lower internal body temperature, which they
maintain even when housed at 4C for several days or when
placed on heating pads at 42C (data not shown). This sug-
gests that hypothalamic control of temperature may become de-
fective after P30 (Boulant, 2000; Laurberg et al., 2005) and could
be partly responsible for the KO phenotype if protein folding is
affected.
The roles of mitochondria and CI in human disease are poorly
understood. Progress in this area has been impeded by the lack
of suitable animal models for research. The KO mice describedCell Metabolism 7, 312–320, April 2008 ª2008 Elsevier Inc. 317
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tochondrial encephalomyopathy, suggesting that theNdufs4 KO
mouse will be a useful genetic model for studying CI deficiencies.
Because we engineered a conditional Ndufs4 allele, CI defi-
ciency can be restricted to specific cell types and the onset of
CI inactivation can be regulated. Thus, by crossing these mice
with various Cre expressor lines, it should be possible to deter-
mine in which cells and when CI activity is required for normal
physiology, behavior, and survival.
EXPERIMENTAL PROCEDURES
Generation of Ndufs4 KO Mice
To create an animal model for CI deficiency, the second exon of Ndufs4 was
flanked by loxP sites using standard gene-targeting techniques in AK18.1 em-
bryonic stem (ES) cells (129/Sv), the Sv-Neo gene was removed by crossing
the mice with Rosa26-FlPer, and the second exon was deleted by crossing
these mice with Mox2-Cre (Figure S1A), which removes exon 2 in the germline
(Tallquist and Soriano, 2000). Mice heterozygous for the Ndufs4 null allele
(Ndufs4D/+) on a mixed 129/Sv3 C57BL/6 genetic background were interbred
to create the homozygous mutant (KO). Absence of NDUFS4 protein was ver-
ified by western analyses with antibodies against NDUFS4 (MitoSciences). KO
mice were born from HET crosses at almost the expected Mendelian ratio
(WT:HET:KO, 1.4:1.9:1.0; n = 790) and could usually be recognized as early
as P16 by their sparse fur or small size.
Animal Experiments
All animal experiments were performed with the approval of the Institutional
Animal Care and Use Committee of the University of Washington. Mice were
maintained on rodent diet (5053, PicoLab) and water available ad libitum in a
vivarium with a 12 hr light/dark cycle at 22C.
Locomotor Activity
Locomotor activity was measured as laser beam breaks in locomotor cham-
bers (Columbus Instruments). Each experiment lasted 48–72 hr, after at least
24 hr habituation to the chamber.
Metabolic Activity
WT and KO mice were placed in metabolic cages (Columbus Instruments), and
measurements of O2, CO2, food, and water consumption were made for 3 con-
secutive days. VO2 was normalized to lean body mass, which was measured
using an Echo Medical Systems EchoMRI-100. The ages of mice ranged from
P26 to P37. Mice were fed ground chow ad libitum (5053, PicoLab), with the
exception of the second night, when they were food deprived. The experiment
was conducted by the Body Composition and Energy Expenditure Core facility
of the Clinical Nutrition Research Unit at the Harborview Hospital, University of
Washington (Seattle).
Body Temperature Monitoring
WT, HET, and KO mice were subdermally implanted with temperature-sensi-
tive probes (IPTT-300, Bio Medic Data Systems) in the scapular region and
allowed to recover for at least 7 days prior to monitoring using telemetric
receivers. Diurnal body temperature was recorded during 2 weeks of 12 hr
light/dark cycles at 25C ambient temperature.
Blood Glucose and Lactate Measurements
Blood was taken from the saphenous vein after an overnight fast. Glucose was
measured using HemoCue B-Glucose microcuvettes. Lactate was measured
using a lactic acid assay kit (Biomedical Research Service Center, The State
University of New York at Buffalo) after plasma isolation using Becton Dickin-
son serum separator tubes.
Hearing
Gross hearing ability was assessed by an automated acoustic startle system
(San Diego Instruments) that records the amplitude of whole-body flinch in
response to bursts of white noise (Davis et al., 1982). In a single session, the318 Cell Metabolism 7, 312–320, April 2008 ª2008 Elsevier Inc.startle response to bursts of 80, 90, 100, 105, 110, and 120 dB was recorded.
Ten rounds of successive sound bursts increasing in amplitude were per-
formed per session.
Ataxia Assays
KO and WT mice were tested for muscular coordination and strength using
the ledge test, negative geotaxis test, grip test, and performance on rotarod
(San Diego Instruments) (see Supplemental Experimental Procedures for
details). Hindlimb clasping was observed during a 10 s tail suspension.
Electroretinogram
Electroretinograms (ERGs) were recorded with a gold wire/contact lens elec-
trode on the cornea in collaboration with J. Hurley (University of Washington)
as described previously (Lyubarsky et al., 2002; Saari et al., 2001) (see Supple-
mental Experimental Procedures for details).
Respiratory Complex Assays of Maximal Enzyme Activity
Enriched mitochondrial extracts were prepared using Dounce homogenization
and differential centrifugation to separate mitochondria from other cell mem-
branes and cytosol. Mitochondria were then sonicated for 10 s on ice using
a Branson Sonifier 250 at 50% pulse and 30% output to generate SMPs for as-
say. Respiratory complex activity was determined by recording the change in
absorbance of decylubiquinone (DB) or NADH in the presence of specific sub-
strates; inhibitors of specific complexes were added to isolate the contribution
of specific complexes (see Supplemental Experimental Procedures for
details).
Polarography
Activities of complexes I, II, and IV were measured by monitoring the rate of
oxygen consumption with an oxygen electrode in the presence of complex-
specific substrates and calculated as the fraction that was sensitive to
complex-specific inhibitors (see Supplemental Experimental Procedures for
details).
Gel Electrophoresis of Protein and DNA
See Supplemental Experimental Procedures for details.
Nuclear Magnetic Resonance Imaging and Optical Spectroscopy
31P-NMR and optical transmission spectra analyses were performed in vivo as
described previously (Blei et al., 1993; Marcinek et al., 2005) (see Supplemen-
tal Experimental Procedures for details).
Histology and Electron Microscopy
Hematoxylin and eosin, ATPase, SDH, COX, Gomori trichrome, and NADH ox-
idase assays were carried out using snap-frozen tissues dissected from soleus
muscle (see Supplemental Experimental Procedures for details).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and five
figures and can be found with this article online at http://www.cellmetabolism.
org/cgi/content/full/7/4/312/DC1/.
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